263 related articles for article (PubMed ID: 36522128)
1. YAP-VGLL4 antagonism defines the major physiological function of the Hippo signaling effector YAP.
Cai J; Choi K; Li H; Pulgar Prieto KD; Zheng Y; Pan D
Genes Dev; 2022 Nov-Dec 1; 36(21-24):1119-1128. PubMed ID: 36522128
[TBL] [Abstract][Full Text] [Related]
2. VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway.
Xu K; Zhao H; Qiu X; Liu X; Zhao F; Zhao Y
Mediators Inflamm; 2020; 2020():8292173. PubMed ID: 33456372
[TBL] [Abstract][Full Text] [Related]
3. VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex.
Zhang W; Gao Y; Li P; Shi Z; Guo T; Li F; Han X; Feng Y; Zheng C; Wang Z; Li F; Chen H; Zhou Z; Zhang L; Ji H
Cell Res; 2014 Mar; 24(3):331-43. PubMed ID: 24458094
[TBL] [Abstract][Full Text] [Related]
4. A Novel Irreversible TEAD Inhibitor, SWTX-143, Blocks Hippo Pathway Transcriptional Output and Causes Tumor Regression in Preclinical Mesothelioma Models.
Hillen H; Candi A; Vanderhoydonck B; Kowalczyk W; Sansores-Garcia L; Kesikiadou EC; Van Huffel L; Spiessens L; Nijs M; Soons E; Haeck W; Klaassen H; Smets W; Spieser SA; Marchand A; Chaltin P; Ciesielski F; Debaene F; Chen L; Kamal A; Gwaltney SL; Versele M; Halder GA
Mol Cancer Ther; 2024 Jan; 23(1):3-13. PubMed ID: 37748190
[TBL] [Abstract][Full Text] [Related]
5. Acetylation of VGLL4 Regulates Hippo-YAP Signaling and Postnatal Cardiac Growth.
Lin Z; Guo H; Cao Y; Zohrabian S; Zhou P; Ma Q; VanDusen N; Guo Y; Zhang J; Stevens SM; Liang F; Quan Q; van Gorp PR; Li A; Dos Remedios C; He A; Bezzerides VJ; Pu WT
Dev Cell; 2016 Nov; 39(4):466-479. PubMed ID: 27720608
[TBL] [Abstract][Full Text] [Related]
6. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL
Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050
[TBL] [Abstract][Full Text] [Related]
7. Two Hippo signaling modules orchestrate liver size and tumorigenesis.
Qi S; Zhong Z; Zhu Y; Wang Y; Ma M; Wang Y; Liu X; Jin R; Jiao Z; Zhu R; Sha Z; Dang K; Liu Y; Lim DS; Mao J; Zhang L; Yu FX
EMBO J; 2023 Jun; 42(11):e112126. PubMed ID: 36919851
[TBL] [Abstract][Full Text] [Related]
8. The tumor suppressor NF2 modulates TEAD4 stability and activity in Hippo signaling via direct interaction.
Wu M; Hu L; He L; Yuan L; Yang L; Zhao B; Zhang L; He X
J Biol Chem; 2024 May; 300(5):107212. PubMed ID: 38522513
[TBL] [Abstract][Full Text] [Related]
9. RHOA activity in expanding blastocysts is essential to regulate HIPPO-YAP signaling and to maintain the trophectoderm-specific gene expression program in a ROCK/actin filament-independent manner.
Marikawa Y; Alarcon VB
Mol Hum Reprod; 2019 Feb; 25(2):43-60. PubMed ID: 30395288
[TBL] [Abstract][Full Text] [Related]
10. Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway.
Miesfeld JB; Link BA
Mech Dev; 2014 Aug; 133():177-88. PubMed ID: 24560909
[TBL] [Abstract][Full Text] [Related]
11. Cyclin-dependent kinase 1 (CDK1)-mediated mitotic phosphorylation of the transcriptional co-repressor Vgll4 inhibits its tumor-suppressing activity.
Zeng Y; Stauffer S; Zhou J; Chen X; Chen Y; Dong J
J Biol Chem; 2017 Sep; 292(36):15028-15038. PubMed ID: 28739871
[TBL] [Abstract][Full Text] [Related]
12. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
Zhu J; Wu T; Lin Q
Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
[TBL] [Abstract][Full Text] [Related]
13. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
Nishina H
Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
[TBL] [Abstract][Full Text] [Related]
14. Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator YAP.
Thines L; Gorisse L; Li Z; Sayedyahossein S; Sacks DB
J Biol Chem; 2022 May; 298(5):101839. PubMed ID: 35307353
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the Hippo Pathway Transcription Factor TEAD.
Lin KC; Park HW; Guan KL
Trends Biochem Sci; 2017 Nov; 42(11):862-872. PubMed ID: 28964625
[TBL] [Abstract][Full Text] [Related]
17. The TEA domain family transcription factor TEAD4 represses murine adipogenesis by recruiting the cofactors VGLL4 and CtBP2 into a transcriptional complex.
Zhang W; Xu J; Li J; Guo T; Jiang D; Feng X; Ma X; He L; Wu W; Yin M; Ge L; Wang Z; Ho MS; Zhao Y; Fei Z; Zhang L
J Biol Chem; 2018 Nov; 293(44):17119-17134. PubMed ID: 30209132
[TBL] [Abstract][Full Text] [Related]
18. HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway.
Geng H; Liu G; Hu J; Li J; Wang D; Zou S; Xu X
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396425
[TBL] [Abstract][Full Text] [Related]
19. The LKB1-TSSK1B axis controls YAP phosphorylation to regulate the Hippo-YAP pathway.
Kim CL; Lim SB; Choi SH; Kim DH; Sim YE; Jo EH; Kim K; Lee K; Park HS; Lim SB; Kang LJ; Jeong HS; Lee Y; Hansen CG; Mo JS
Cell Death Dis; 2024 Jan; 15(1):76. PubMed ID: 38245531
[TBL] [Abstract][Full Text] [Related]
20. The Hippo pathway in tissue homeostasis and regeneration.
Wang Y; Yu A; Yu FX
Protein Cell; 2017 May; 8(5):349-359. PubMed ID: 28130761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
